These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study. Choi MH; Yoon JH; Yong SW J Neurol Sci; 2017 Oct; 381():291-295. PubMed ID: 28991700 [TBL] [Abstract][Full Text] [Related]
25. Normal 'heart' in Parkinson's disease: is this a distinct clinical phenotype? Kim JS; Park HE; Park IS; Oh YS; Ryu DW; Song IU; Jung YA; Yoo IR; Choi HS; Lee PH; Lee KS Eur J Neurol; 2017 Feb; 24(2):349-356. PubMed ID: 27888574 [TBL] [Abstract][Full Text] [Related]
26. Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease. Watanabe M; Takeda T; Nakamagoe K; Tamaoka A Eur J Neurol; 2011 Jul; 18(7):1010-3. PubMed ID: 21658161 [TBL] [Abstract][Full Text] [Related]
27. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy. Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077 [TBL] [Abstract][Full Text] [Related]
28. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease. Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056 [TBL] [Abstract][Full Text] [Related]
29. Cardiovascular dysautonomia in de novo Parkinson's disease without orthostatic hypotension. Oka H; Toyoda C; Yogo M; Mochio S Eur J Neurol; 2011 Feb; 18(2):286-292. PubMed ID: 20602633 [TBL] [Abstract][Full Text] [Related]
30. Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease. Kitayama M; Wada-Isoe K; Irizawa Y; Nakashima K J Neurol Sci; 2008 Jan; 264(1-2):22-6. PubMed ID: 17706675 [TBL] [Abstract][Full Text] [Related]
31. [Relationship between cardiac 123I-metaiodobenzylguanidine scintigraphy and cardiovascular autonomic function test (standing test) in Parkinson's disease]. Doi H; Niimi Y; Hasegawa Y; Miwa S; Yamana T; Takagi S; Takahashi A; Sobue G Rinsho Shinkeigaku; 2008 Jan; 48(1):56-9. PubMed ID: 18386634 [TBL] [Abstract][Full Text] [Related]
32. 24-Hour Ambulatory Blood Pressure Monitoring in SWEDDs Patients With Parkinsonism. Kang SJ; Ahn JY; Kim JS; Cho JW; Kim JY; Choi YY; Kim HT Can J Neurol Sci; 2016 May; 43(3):390-7. PubMed ID: 26853109 [TBL] [Abstract][Full Text] [Related]
33. Dobutamine stress test unmasks cardiac sympathetic denervation in Parkinson's disease. Nakamura T; Hirayama M; Ito H; Takamori M; Hamada K; Takeuchi S; Watanabe H; Koike Y; Sobue G J Neurol Sci; 2007 Dec; 263(1-2):133-8. PubMed ID: 17673233 [TBL] [Abstract][Full Text] [Related]
34. Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease. Iijima M; Osawa M; Momose M; Kobayakawa T; Saito S; Iwata M; Uchiyama S Mov Disord; 2010 Jul; 25(9):1143-9. PubMed ID: 20131383 [TBL] [Abstract][Full Text] [Related]
35. Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms? Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F Parkinsonism Relat Disord; 2006 Jun; 12(5):284-8. PubMed ID: 16549383 [TBL] [Abstract][Full Text] [Related]
36. Neurological applications for myocardial MIBG scintigraphy. Lucio CG; Vincenzo C; Antonio R; Oscar T; Antonio R; Luigi M Nucl Med Rev Cent East Eur; 2013; 16(1):35-41. PubMed ID: 23677762 [TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of patients with Parkinson's disease with reduced Ebina J; Mizumura S; Morioka H; Shibukawa M; Nagasawa J; Yanagihashi M; Hirayama T; Ishii N; Kobayashi Y; Inaba A; Orimo S; Kano O J Neurol Sci; 2024 Mar; 458():122932. PubMed ID: 38401301 [TBL] [Abstract][Full Text] [Related]
38. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697 [TBL] [Abstract][Full Text] [Related]
39. [Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson's disease: assessment of cardiac sympathetic denervation]. Satoh A; Serita T; Tsujihata M Nihon Rinsho; 1997 Jan; 55(1):202-6. PubMed ID: 9014450 [TBL] [Abstract][Full Text] [Related]
40. Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy. Nagamachi S; Wakamatsu H; Kiyohara S; Fujita S; Futami S; Tamura S; Nakazato M; Yamashita S; Arita H; Nishii R; Kawai K Ann Nucl Med; 2008 Aug; 22(7):557-64. PubMed ID: 18756357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]